Israeli drug maker Teva Pharmaceutical Industries Ltd. said Sunday it will be firing some 350 workers from its Teva-Tech factory in Neot Hovav in southern Israel as part of a “significant” efficiency program that will take place at the unit.
The program, which will be implemented in the first quarter of 2022, will also see a change to the mix of products and the scope of activity at the plant, which produces active pharmaceutical ingredients for Teva and other pharma firms globally, the company said in a statement.
